Isabel Fabregat

24PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMolecular targetsWastewater treatment processesCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Sep 13, 2025
Regulatory Mechanisms of SPARC Overexpression in Melanoma Progression.

Antònia Vinyals, Josep R Ferreres, Rafael Campos-Martín

|Sep 10, 2025
New Experimental Mouse Models to Evaluate the Role of Transforming Growth Factor-Beta in Liver Tumorigenesis.

Ana Cantos-Cortes, Josep Amengual, Rut Espinosa-Sotelo

|Aug 17, 2025
NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts.

Josep Amengual, Ester Gonzalez-Sanchez, Mariana Yáñez-Bartolome

|Jun 13, 2025
Inhibiting the TGF-β1 Pathway Reduces the Aggressiveness of Intrahepatic CCA HuCCT1 CD90-Positive Cells.

Elena Pizzuto, Serena Mancarella, Isabella Gigante

|Mar 27, 2025
New Hepatocellular Carcinoma (HCC) Primary Cell Cultures as Models for Exploring Personalized Anti-TGF-β Therapies Based on Tumor Characteristics.

Rosanna Scialpi, Rut Espinosa-Sotelo, Esther Bertran

|Sep 17, 2024
Iron chelation as a new therapeutic approach to prevent senescence and liver fibrosis progression.

Josep Amengual, Ania Alay, Javier Vaquero

Pageof 4